Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;54 Suppl 4(Suppl 4):S324-7.
doi: 10.1093/cid/cir993.

Prevalence of transmitted HIV drug resistance among newly diagnosed antiretroviral therapy-naive pregnant women in Lilongwe and Blantyre, Malawi

Nellie Wadonda-Kabondo  1 , Richard Banda, Kundai Moyo, Maurice M'bang'ombe, Mabvuto Chiwaula, Carol Porter, Michael R Jordan
Affiliations

Prevalence of transmitted HIV drug resistance among newly diagnosed antiretroviral therapy-naive pregnant women in Lilongwe and Blantyre, Malawi

Nellie Wadonda-Kabondo et al. Clin Infect Dis. 2012 May.

Abstract

In 2006, a survey of transmitted human immunodeficiency virus (HIV) drug resistance (TDR) was conducted in Lilongwe, Malawi. The survey followed the World Health Organization method to classify TDR to nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs) among primigravid women aged <25 years. Results of the 2006 survey showed <5% TDR in all drug classes. In 2009, TDR surveys using the same method were repeated in Lilongwe and expanded to Blantyre. Findings show that in Lilongwe TDR to NRTIs and PIs was <5%, whereas TDR to NNRTIs was 5%-15%. In Blantyre, TDR was <5% to all drug classes. Observed moderate TDR in Lilongwe is cause for concern and signals the need for closer monitoring of Malawi's antiretroviral therapy program.

PubMed Disclaimer

References

    1. Ministry of Health. HIV sentinel surveillance report. Lilongwe, Malawi: 2007.
    1. Ministry of Health. Quarterly HIV programme report, HIV testing and counseling, prevention of mother to child transmission, antiretroviral therapy, treatment of sexually transmitted infections. Lilongwe, Malawi: 2010.
    1. WHO, UNAIDS, and UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report, September 2009. Geneva, Switzerland: World Health Organization; 2010. . Available at: http://www.who.int/hiv/pub/2009progressreport/en/index.html. Accessed 15 July 2011.
    1. Somi GR, Kibuka T, Diallo K, et al. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania. Antivir Ther. 2008;13(Suppl 2):77–82. - PubMed
    1. Bessong PO, MPhahlele J, Choge IA, et al. Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals. AIDS Res Hum Retroviruses. 2006;22:1306–12. - PubMed

Publication types

Substances